BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5467 related articles for article (PubMed ID: 441722)

  • 1. [Histopathologic classification of malignant melanoma of the skin. Retrospective study of 149 cases].
    Hauser C; Gloor F
    Schweiz Med Wochenschr; 1979 Feb; 109(5):152-7. PubMed ID: 441722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant melanoma: depth of invasion and histologic typing].
    Hermanek P; Hornstein OP; Tonak J; Weidner F
    Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrosepctive histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):361-6. PubMed ID: 525350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
    Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)].
    Pelletier N; Claudy A; Thivolet J
    Dermatologica; 1978; 157(4):210-20. PubMed ID: 689232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous melanomas in old patients. Prognostic factors and actuarial survival].
    Ortolani C; Paz RA
    Medicina (B Aires); 1992; 52(1):23-9. PubMed ID: 1302287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous melanomas that defy conventional prognostic indicators.
    McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
    Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of thorough block sampling in the histologic evaluation of melanomas.
    Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
    Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant melanomas of Lille 1967-1972. Comparison between "histoprognosis" and actual outcome (author's transl)].
    Vandenbussche F; Lekieffre M; Meresse B; Lagache G; Bombart-Thoreux M; Bergoend H; Benoit M; Houcke M; Brouet J; Huriez C
    Acta Chir Belg; 1975 Jul; 74(4):406-21. PubMed ID: 1146461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 274.